GSK plc

NYSE

Market Cap.

74.5B

Avg. Volume

4.87M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about GSK plc

GSK plc News

GSK plc Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock
Website screenshot
HealthcareDrug Manufacturers - General
gsk.com

About GSK plc

GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

GSK plc Earnings & Revenue

GSK plc Financials

Table Compare

Compare GSK metrics with:

   

Earnings & Growth

GSK

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

GSK

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

GSK

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

GSK

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

GSK plc Income

GSK plc Balance Sheet

GSK plc Cash Flow

GSK plc Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityStrong Sell
Return on AssetsStrong Sell
Debt/Equity RatioStrong Sell
Price/Earnings RatioStrong Sell
Price/Book RatioStrong Sell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

GSK plc Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

1.5441

Payment DateDividendFrequency
2025-04-100.39315Quarterly
2025-01-090.38905Quarterly
2024-10-100.38567Quarterly
2024-07-110.37619Quarterly
2024-04-110.40606Quarterly

GSK plc Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Historical Market Cap

Shares Outstanding

GSK plc Executives

NameRole
Ms. Emma Natasha WalmsleyChief Executive Officer & Director
Ms. Julie Belita Brown A.C.A.Chief Financial Officer & Executive Director
Mr. James FordSenior Vice President & Group General Counsel of Legal & Compliance
Ms. Diana ConradChief People Officer
Mr. Tony WoodChief Scientific Officer and Head of R&D
NameRoleGenderDate of BirthPay
Ms. Emma Natasha WalmsleyChief Executive Officer & DirectorFemale19696.68M
Ms. Julie Belita Brown A.C.A.Chief Financial Officer & Executive DirectorFemale19626.38M
Mr. James FordSenior Vice President & Group General Counsel of Legal & ComplianceMale

--

Ms. Diana ConradChief People OfficerFemale

--

Mr. Tony WoodChief Scientific Officer and Head of R&DMale

--

Discover More

Streamlined Academy

GSK plc

NYSE

Market Cap.

74.5B

Avg. Volume

4.87M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

GSK plc News

GSK plc Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock

GSK plc Earnings & Revenue

GSK plc Income

GSK plc Balance Sheet

GSK plc Cash Flow

GSK plc Financials Over Time

GSK plc Executives

NameRole
Ms. Emma Natasha WalmsleyChief Executive Officer & Director
Ms. Julie Belita Brown A.C.A.Chief Financial Officer & Executive Director
Mr. James FordSenior Vice President & Group General Counsel of Legal & Compliance
Ms. Diana ConradChief People Officer
Mr. Tony WoodChief Scientific Officer and Head of R&D
NameRoleGenderDate of BirthPay
Ms. Emma Natasha WalmsleyChief Executive Officer & DirectorFemale19696.68M
Ms. Julie Belita Brown A.C.A.Chief Financial Officer & Executive DirectorFemale19626.38M
Mr. James FordSenior Vice President & Group General Counsel of Legal & ComplianceMale

--

Ms. Diana ConradChief People OfficerFemale

--

Mr. Tony WoodChief Scientific Officer and Head of R&DMale

--

GSK plc Insider Trades

No data available

DateNameRoleTransactionTypeShares

No data available

Streamlined Academy

Website screenshot
HealthcareDrug Manufacturers - General
gsk.com

About GSK plc

GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about GSK plc

GSK plc Financials

Table Compare

Compare GSK metrics with:

   

Earnings & Growth

GSK

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

GSK

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

GSK

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

GSK

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

GSK plc Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

1.5441

Payment DateDividendFrequency
2025-04-100.39315Quarterly
2025-01-090.38905Quarterly
2024-10-100.38567Quarterly
2024-07-110.37619Quarterly
2024-04-110.40606Quarterly

GSK plc Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityStrong Sell
Return on AssetsStrong Sell
Debt/Equity RatioStrong Sell
Price/Earnings RatioStrong Sell
Price/Book RatioStrong Sell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More

A Practical Guide: How To Analyze Any Stock (With Examples)